Gli A.A. descrivono i risultati ottenuti in base alle caratteristiche cliniche di 123 pazienti sottoposti a chemonucleolisi con un follow-up da un minimo di 6 mesi a un massimo di oltre 2 anni. Il risultato è stato ottimo o buono nell '82,1% dei casi. Vengono esaminate in maniera analitica le cause dei risultati insoddisfacenti. Si sottolinea come una rigorosa selezione clinica e neuroradiologica sia basilare per il successo di questa metodica. La Chemonucleolisi è un presidio terapeutico complementare alla discectomia chirurgica costituendo un progresso per la sua semplicità e relativa innocuità, se condotto in centri specializzati. L'applicazione di tale metodica ha notevolmente accresciuto la fattiva collaborazione tra due reparti diversi, ma strettamente complementari.
ApfelbachHWJacobsRLRayRD: Chemonucleolysis in the treatment of low back pain and sciatica. Surg Clin North Am55: 181–197, 1975.
2.
BenoistMDeburgeA: La Chimonucléolyse dans le traitment des sciatiques discales: 120 observations. Presse Med11: 2121–2124, 1982.
3.
BenoistM: Positioning alternatives for chemonucleolysis. Current Concepts in Chemonucleolysis, the Royal Society of Medicine, Ed.London1985: pag. 47–53.
4.
BenoistM: Experience of chemonucleolysis in France, Belgium and Italy. Current Concepts in Chemonucleolysis, The Royal Society of Medicine, Ed.London1985: pag. 126–136.
5.
BenoistM: Chimionucleolyse. Cahiers d'enseignement de la SOFCOT, 26. Expansion Scientifique, Ed.1986: pag. 71–88.
6.
BersiG: Chimonucleolisi. Analisi dei risultati (140 casi). Atti I Simp. Europeo su Lombalgia e Lombosciatalgia. Ed. Libreria Cortina Torino, 1982.
7.
BonnevilleJF: Focus on Chemonucleolysis. Springer Verlag, Heidelberg1985.
8.
BouilletR: Complications de la nucléolyse (2136 patients). Acta Orth Belgica49: 49–77, 1983.
9.
BouilletR: Complications de la Chemonucleolyse. Etude de 18.925 dossier provenant de 155 departements. Comunications Congres Orthopaedica Belgica - Bruxelles 22–24 mai 1986.
10.
BradfordDSCooperKMOegemaTR: Chymopapain, Chemonucleolysis, and Nucleus Pulposus Regeneration. J Bone Joint Surg65-A: 1220–1230, 1983.
11.
BromelyJM: Lumbar intervertebral discolysis with collagenase. Spine8: 322–324, 1983.
12.
CarrutherCCKousaieKN: Surgical treatment after Chemonucleolysis failure. Clin Orthop165: 172–175, 1982.
13.
ChevrotABellinMF: Discography and Nucleolysis with Disease. Focus on Chemonucleolysis, Springer Verlag, Heidelberg1986, pag. 59–65.
14.
ClerePRungeMBonnevilleJF: Results after Chemonucleolysis. Focus on Chemonucleolysis, Springer Verlag, Heidelberg1986, pag. 59–65.
15.
CrawshawCFrazerAM: A comparison of surgery and chemonucleolysis in the treatment of sciatica: a prospective randomized trial. Spine9: 195, 1984.
16.
DabeziesEJBeckCShojiH: Chymopapain in Perspective. Clin Orthop206: 10–14, 1986.
17.
DeburgeABenoistMHeripretG: Indications et contre-indications de la nucléolyse. Vie méd62: 127–134, 1981.
18.
DeramondH: Failures of Chemonucleolysis. Focus on Chemonucleolysis, Springer Verlag, Heidelberg1986, pag. 107–113.
19.
FabrisGLeonardiM: Sulla nucleolisi enzimatica dell'ernia discale lombare. Collana di Neurochirurgia, Moderna Ed., Napoli1987.
FlanaganNSmithL: Clinical Studies of Chemonucleolysis Patients with Ten to Twenty-Year Follow-up Evaluation. Clin Orthop206: 15–17, 1986.
22.
FraserRD: Chymopapain for the treatment of intervertebral disc prolapse. A double blind study. Spine7: 608–612, 1982.
23.
GarvinPIJenningsRB: Long-term Effects of Chymopapain on Intervertebral Disks of Dogs. Clin Orthop92: 281–295, 1973.
24.
GrammerLCRickettiAJ: Chymopapain Allergy: case reports and Identification of Patiens at Risk for Chymopapain Anaphylaxis. Clin Orthop188: 139–143, 1984.
25.
LavignolleB: Evaluation des chances de succes de la nucleolyse - Analyse du protocole de la chemonucleolyse sur un serie de 423 patients. 4ème Journèes de Chirurgie du Rachis, Benoist Ed.Paris, 1983.
26.
LazorthesYRichaudJ: La Chemonucleolyse dans le traitement des sciatiques chirurgicales. Neurochirurgie31: 471–493, 1985.
27.
McCullochJA: Chemonucleolysis. J Bone Joint Surg (Br)59-B: 42–52, 1977.
28.
McCullochJA: Chemonucleolysis Experience with 2000 cases. Clin Orthop146: 128–134, 1980.
NordbyEJ: Comparison of Surgery and Chemonucleolysis. Current Conepts in Chemonucleolysis. The Royal Society of Medicine, Ed.London1985: pag. 197–201.
41.
OnofrioBM: Injection of chymopapain into intervertebral discs. Preliminary report on 72 patients with symptoms of disc disease. J Neurosurg42: 384–388, 1975.
42.
ParkinsonD: Late results of treatment of intervertebral disc disease with chymopapain. J Neurosurg59: 990–993, 1983.
43.
PostacchiniF: La chimonucleolisi. Primi risultati. Giorn Ital Ortop Traum10: 5–21, 1984.
44.
SalviVBouxE: La Chimonucleolisi con Chimopapaina nell'ernia discale lombare. Considerazioni sui primi 100 casi con controllo da 6 mesi a 3 anni. Min Ortop37: 123–132, 1986.
SmithL: Enzyme dissolution of the nucleus pulposus in humans. JAMA187: 137–140, 1964.
47.
SokalRRRohlfFJ: BiometryW.H. Freeman and Co. Ed., San Francisco CA1981.
48.
SuttonJR: Post-operative care - A pratical review; Current Concepts in Chemonucleolysis. The Royal Society of Medicine, Ed.London1985: pag. 71–76, 1985.
49.
SuttonJC: Canadian experience with chemonucleolysis. Current Conepts in Chemonucleolysis. The Royal Society of Medicine, Ed.London1985: pag. 167–179, 1985.
50.
TroisierODewerpePPellerayB: Bilan de cinq année de traitement par nucléolyse de 150 radiculalgies et 10 lombalgies. Rev Rhum Mal Ostéoartic49: 377–383, 1982.
51.
TroisierO: Technique de la discographie extradurale. J Radiol63: 571–578, 1982.
52.
VirchowR: Untersuchung über die Entwicklung des Schädelgrundes im gesunden und krankhaften Zustande und über den Einfluss-derselben auf Schädelform. Gesichtsbildung und Gebirnbau, Berlin, 1857.
53.
WeinsteinJNLehmannTR: Chemonucleolysis versus Open Discectomy. Clin Orthop206: 50–55, 1986.
54.
WiltseILWidellEHYuanHA: Chymopapain chemonucleolysis in lumbar disc disease. Jama231: 474–474, 1975.
